KAYLA JONES: Open Payments
NPI 1528553013 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 8 payments from 5 companies in 2025. Trend: 2023 $336 · 2024 $900 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $385 |
| Madrigal Pharmaceuticals | 2 | $275 |
| ABBVIE INC. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $111 |
| Boston Scientific Corporation | 1 | $50 |
Products named: REZDIFFRA, EVENITY, LINZESS, Epclusa, APOLLO ESG System.
Industry payments across IL — which companies pay providers there.
